News
AVGR
1.605
-16.41%
-0.315
Why Streamline Health Solutions Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Streamline Health Solutions, Inc. Shares dipped 23.3% to $0.4902 on Wednesday. The company reported worse-than-expected first-quarter EPS results. DDC Enterprise Limited (NYSE:DDC) surged 101% in today's mid-day session.
Benzinga · 5h ago
12 Health Care Stocks Moving In Wednesday's Intraday Session
Longeveron (NASDAQ:LGVN) shares rose 112.1% to $1.74 during Wednesday's regular session. VTv Therapeutics stock increased by 43.09% to $26.0. Avidity Biosciences shares increased by 32.32% during the session. ThermoGenesis Holdings shares fell 31.4% in the same session.
Benzinga · 6h ago
Weekly Report: what happened at AVGR last week (0603-0607)?
Weekly Report · 2d ago
BUZZ-U.S. STOCKS ON THE MOVE-Gold miners , Cytokinetics, Novavax
Technology stocks led U.S. Indexes higher on Wednesday. The Dow Jones Industrial Average was up 0.10% at 38,750.72. The top three S&P 500 percentage gainers were Hewlett Packard Enterprise, 3D Systems. The Nasdaq Composite was up 1.61%.
Reuters · 06/05 17:59
Health Care Sector Update for 06/05/2024: CYTK, ACET, AVGR
NASDAQ · 06/05 17:52
BUZZ-U.S. STOCKS ON THE MOVE-Chemours, Hyster-Yale, Guidewire
The S&P 500 and the Nasdaq edged up on Wednesday. The Dow Jones Industrial Average was up 0.04% at 38,726.01. The top three percentage gainers on the NYSE were 3D Systems, Applied Materials and Stitch Fix. Hyster-Yale and Chemours were among the biggest losers.
Reuters · 06/05 15:46
BUZZ-Avinger announces job cuts in unit; shares rise
Medical device company Avinger announces job cuts in its peripheral artery disease business. Shares of medical device company rise 12.7% to $2.12. Job cuts expected to provide significant cost savings in second half of 2024. Company will increase focus on coronary artery disease program.
Reuters · 06/05 13:55
AVINGER INC - REDUCED HEADCOUNT DEDICATED TO ITS PERIPHERAL BUSINESS BY 33%
Reuters · 06/05 11:33
AVINGER INC - WILL INCREASE FOCUS ON ITS CORONARY ARTERY DISEASE PROGRAM
Reuters · 06/05 11:33
Weekly Report: what happened at AVGR last week (0527-0531)?
Weekly Report · 06/03 10:19
AVINGER- ON MAY 29, NOTIFIED BY NASDAQ, CO REGAINED COMPLIANCE WITH STOCKHOLDERS’ EQUITY REQUIREMENT SET FORTH IN NASDAQ LISTING RULE 5550(B)(1)
Reuters · 05/31 13:02
Weekly Report: what happened at AVGR last week (0520-0524)?
Weekly Report · 05/27 10:21
Avinger files for common stock and warrants offering
Seeking Alpha · 05/24 21:34
*Avinger to Offer Stock and Warrants
Dow Jones · 05/24 21:24
Weekly Report: what happened at AVGR last week (0513-0517)?
Weekly Report · 05/20 10:17
Avinger Converts $11M Of CRG Debt Into Preferred Equity
Avinger, Inc. Converts 80% of its existing debt into shares of convertible preferred stock. The company is developing the first and only intravascular image-guided, catheter-based systems for diagnosis and treatment of vascular disease. The debt conversion results in an $11 million increase in stockholders' equity.
Benzinga · 05/16 20:28
Avinger’s Strategic Equity Restructuring with CRG Partners
TipRanks · 05/16 20:25
AVGR Stock Earnings: Avinger Misses EPS, Misses Revenue for Q1 2024
Avinger reported results for the first quarter of 2024. The company reported earnings per share of -$ and revenue of $ million. This was below the analyst estimate for EPS of $ -$ Avinger's revenue was also below the estimate for the quarter.
Investorplace · 05/16 00:54
AVINGER Q1 GROSS PROFIT USD 343 THOUSAND
Reuters · 05/15 20:14
Asensus Surgical (ASXC) Reports Q1 Loss, Tops Revenue Estimates
NASDAQ · 05/14 21:55
More
Webull provides a variety of real-time AVGR stock news. You can receive the latest news about Avinger Inc through multiple platforms. This information may help you make smarter investment decisions.
About AVGR
Avinger, Inc. is a commercial-stage medical device company. The Company designs, manufactures, and sells real-time, image-guided, minimally invasive catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). Its Lumivascular platform includes the Lightbox real-time imaging console, the Ocelot and Tigereye family of catheters, which are image-guided catheters designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO), and the Pantheris family of catheters, its image-guided atherectomy family of catheters designed to allow physicians to remove arterial plaque in PAD patients. Its Pantheris is a single-use product and provides physicians with the ability to see a cross-sectional view of the peripheral artery to guide the removal of blockages throughout the procedure. It has also developed a line extension of its Pantheris image-guided atherectomy platform, Pantheris Small Vessel (SV).